» Articles » PMID: 10735498

Specifically Regulated Genes in Malignant Melanoma Tissues Identified by Subtractive Hybridization

Overview
Journal Br J Cancer
Specialty Oncology
Date 2000 Mar 29
PMID 10735498
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A polymerase chain reaction (PCR)-based subtractive hybridization technique was used to identify transformation-related genes in malignant melanoma. Melanoma biopsies were compared with tissues of benign melanocytic naevi and 549 gene fragments were screened using arrayed filters. Thirty-eight clones were confirmed to be differentially expressed representing 30 different genes (18 melanoma-specific and 12 naevus-specific genes). To further confirm differential gene expression, Northern blot analyses with six of the 30 genes as probes were performed. All six were differentially expressed in benign and malignant melanocytic lesions, specifically dbpB/YB-1, 67-kDa laminin receptor, CAGH-3, 71-kDa heat shock protein and two unknown genes. The expression levels of these genes were then analysed in 50 different tissues to determine their overall expression profile. In conclusion, the technique of PCR-based subtractive hybridization in combination with arrayed filters allows detection of differences in gene expression even in tissues from which high-quality RNA is hard to isolate. The genes identified in this study are of interest because of their potential role in the pathogenesis of malignant melanoma.

Citing Articles

Long-lasting molecular changes in human skin after repetitive in situ UV irradiation.

Brenner M, Coelho S, Beer J, Miller S, Wolber R, Smuda C J Invest Dermatol. 2008; 129(4):1002-11.

PMID: 18946495 PMC: 2709208. DOI: 10.1038/jid.2008.325.


A mathematical model for suppression subtractive hybridization.

Gadgil C, Rink A, Beattie C, Hu W Comp Funct Genomics. 2008; 3(5):405-22.

PMID: 18629052 PMC: 2447336. DOI: 10.1002/cfg.206.


Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.

Zuidervaart W, van der Velden P, Hurks M, van Nieuwpoort F, Out-Luiting C, Singh A Br J Cancer. 2003; 89(10):1914-9.

PMID: 14612903 PMC: 2394439. DOI: 10.1038/sj.bjc.6601374.


Current awareness on comparative and functional genomics.

Yeast. 2000; 17(3):255-62.

PMID: 11025539 PMC: 2448367. DOI: 10.1002/1097-0061(20000930)17:3<255::AID-YEA9>3.0.CO;2-7.

References
1.
Herlyn M, Shih I . Interactions of melanocytes and melanoma cells with the microenvironment. Pigment Cell Res. 1994; 7(2):81-8. DOI: 10.1111/j.1600-0749.1994.tb00025.x. View

2.
Rodeck U . Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Rev. 1993; 12(3-4):219-26. DOI: 10.1007/BF00665954. View

3.
Siebert P, Chenchik A, Kellogg D, Lukyanov K, Lukyanov S . An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res. 1995; 23(6):1087-8. PMC: 306810. DOI: 10.1093/nar/23.6.1087. View

4.
Reed J, Loganzo Jr F, Shea C, Walker G, Flores J, Glendening J . Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995; 55(13):2713-8. View

5.
Kudo S, Mattei M, Fukuda M . Characterization of the gene for dbpA, a family member of the nucleic-acid-binding proteins containing a cold-shock domain. Eur J Biochem. 1995; 231(1):72-82. DOI: 10.1111/j.1432-1033.1995.tb20672.x. View